Evidence
Alzheimers Dement. 2024 Jan 25. doi: 10.1002/alz.13692. Online ahead of print.
ABSTRACT
Individuals with Down syndrome (DS) have a partial or complete trisomy of chromosome 21, resulting in an increased risk for early-onset Alzheimer’s disease (AD)-type dementia by early midlife. Despite ongoing clinical trials to treat late-onset AD, individuals with DS are often excluded. Furthermore, timely diagnosis or management is often not available. Of the genetic causes of AD, people with DS represent the largest cohort. Currently, there is a knowledge gap regarding the underlying neurobiological mechanisms of DS-related AD (DS-AD), partly due to limited access to well-characterized brain tissue and biomaterials for research. To address this challenge, we created an international consortium of brain banks focused on collecting and disseminating brain tissue from persons with DS throughout their lifespan, named the Down Syndrome Biobank Consortium (DSBC) consisting of 11 biobanking sites located in Europe, India, and the USA. This perspective describes the DSBC harmonized protocols and tissue dissemination goals.
PMID:38270275 | DOI:10.1002/alz.13692
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Down Syndrome Biobank Consortium: A perspective
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- The Alzheimer's Disease Neuroimaging Initiative Clinical Core
- Assessing amyloid PET positivity and cognitive function in Down syndrome to guide clinical trials targeting amyloid
- Evidence for a novel neuronal mechanism driving Alzheimer's disease, upstream of amyloid
- Advancements in dementia research, diagnostics, and care in Latin America: Highlights from the 2023 Alzheimer's Association International conference satellite symposium in Mexico City
- Diabetes accelerates Alzheimer's disease progression in the first year post mild cognitive impairment diagnosis
- Extended genome-wide association study employing the African genome resources panel identifies novel susceptibility loci for Alzheimer's disease in individuals of African ancestry
- HbA(1c) variability associated with dementia risk in people with type 2 diabetes
- Novel measures of cognition and function for the AD spectrum in the Novel Measures for Alzheimer's Disease Prevention Trials (NoMAD) project: Psychometric properties, convergent validation, and contrasts with established measures
- Rare Case of a 20p13 Duplication Trisomy With Craniostenosis
- Neuroimaging correlates of Alzheimer's disease biomarker concentrations in a racially diverse high-risk cohort of middle-aged adults
- Cancer research provides a model for advancing clinical trials in dementia in the era of disease-modifying Alzheimer's-type dementia therapies
- Contributions of the ADNI Biostatistics Core
- Association of neuroticism with incident dementia, neuroimaging outcomes, and cognitive function
- How many future dementia cases would be missed by a high-risk screening program? A retrospective cohort study in a population-based cohort
- A Framework for Best Practices and Readiness in the Advent of Anti-Amyloid Therapy for Early Alzheimer's Disease in Asia
- Decentralized clinical trials for medications to reduce the risk of dementia: Consensus report and guidance
- Clinical Manifestations
- The risk of Alzheimer's disease and cognitive impairment characteristics in eight mental disorders: A UK Biobank observational study and Mendelian randomization analysis
- Subsyndromes and symptom clusters: Multilevel factor analysis of behavioral and psychological symptoms of dementia with intensive longitudinal data
- Lecanemab and Vascular-Amyloid Deposition in Brains of People With Down Syndrome
- Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
- Development of thresholds and a visualization tool for use of a blood test in routine clinical dementia practice
- Cryo-EM structures reveal tau filaments from Down syndrome adopt Alzheimer's disease fold
- Expansion of highly interferon-responsive T cells in early-onset Alzheimer's disease
- Occurrence of mosaic Down syndrome and prevalence of co-occurring conditions in Medicaid enrolled adults, 2016-2019
- Long-term impact of type 2 diabetes onset on dementia incidence rate among New Zealanders with impaired glucose tolerance: A tapered-matched landmark analysis over 25 years
- Temporo-frontoparietal hypoconnectivity as a biomarker for isolated language impairment in mild cognitive impairment: A cross-cohort comparison
- Expanding the phenotype of neurofibromatosis type 1 microdeletion syndrome
- Cerebrospinal fluid p-tau181, 217, and 231 in definite Creutzfeldt-Jakob disease with and without concomitant pathologies
- Effect of gamification with a support partner to increase physical activity in older adults at risk for Alzheimer's disease: The STEP 4Life randomized clinical trial
- Neuropsychiatric symptom burden in early-onset and late-onset Alzheimer's disease as a function of age
- Primary Microgliopathy Presenting as Degenerative Dementias: A Case Series of Novel Gene Mutations from India
- (18)F-FDG PET can effectively rule out conversion to dementia and the presence of CSF biomarker of neurodegeneration: a real-world data analysis
- MRI-derived brain iron, grey matter volume, and risk of dementia and Parkinson's disease: Observational and genetic analysis in the UK Biobank cohort
- Mild behavioral impairment domains are longitudinally associated with pTAU and metabolic biomarkers in dementia-free older adults
- Association of cognitive reserve with transitions across cognitive states and death in older adults: A 15-year follow-up study
- Unexpected Low Rate of Amyloid-β Pathology in Multiple Sclerosis Patients
- Brain Age Gap in Early Illness Schizophrenia and the Clinical High-Risk Syndrome: Associations With Experiential Negative Symptoms and Conversion to Psychosis
- Vitamin D, Alzheimer's disease and related dementia
- Narrative review on ethical and psychological issues raised by genetic and genomic testing in pediatric oncology care
- Systemic inflammatory markers in ageing, Alzheimer's disease and other dementias
- X centromeric drive may explain the prevalence of polycystic ovary syndrome and other conditions: Genomic structure of the human X chromosome pericentromeric region is consistent with meiotic drive associated with PCOS and other conditions
- X centromeric drive may explain the prevalence of polycystic ovary syndrome and other conditions: Genomic structure of the human X chromosome pericentromeric region is consistent with meiotic drive associated with PCOS and other conditions
- Prenatal Diagnosis of Myhre Syndrome in Two Cases: Further Delineation of the Cardiac and External Phenotype
- Gender-specific analysis of social connection patterns and risk of dementia in community-dwelling older people
- Leptin bioavailability and markers of brain atrophy and vascular injury in the middle age
- Clinical criteria for a limbic-predominant amnestic neurodegenerative syndrome
- CSF glial biomarkers are associated with cognition in individuals at risk of Alzheimer's disease
- Diffusion imaging genomics provides novel insight into early mechanisms of cerebral small vessel disease
- Diffusion imaging genomics provides novel insight into early mechanisms of cerebral small vessel disease
- Amyloid and SCD jointly predict cognitive decline across Chinese and German cohorts
- Developing Topics
- Bayesian genome-wide TWAS with reference transcriptomic data of brain and blood tissues identified 141 risk genes for Alzheimer's disease dementia
- Post-GWAS multiomic functional investigation of the TNIP1 locus in Alzheimer's disease highlights a potential role for GPX3
- Caregiver coping mediates the relationship between caregivers' understanding of dementia as terminal and their distress
- Using Organoids to Model Sex Differences in the Human Brain
- Prospective Effects of Self-Rated Health on Dementia Risk in Two Twin Studies of Aging
- Transcranial alternating current stimulation (tACS) at gamma frequency: an up-and-coming tool to modify the progression of Alzheimer's Disease
- The PREVENT dementia programme: baseline demographic, lifestyle, imaging and cognitive data from a midlife cohort study investigating risk factors for dementia
- Cognitive integrity in Non-Demented Individuals with Alzheimer's Neuropathology is associated with preservation and remodeling of dendritic spines
- Investigating the brain's neurochemical profile at midlife in relation to dementia risk factors
- Racial and ethnic differences in the risk of dementia diagnosis under hypothetical blood pressure-lowering interventions: The Multi-Ethnic Study of Atherosclerosis
- Significance of plasma p-tau217 in predicting long-term dementia risk in older community residents: Insights from machine learning approaches
- Genetic biomarkers of cognitive impairment and dementia of potential interest in CKD patients
Evidence Blueprint
Down Syndrome Biobank Consortium: A perspective
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Down Syndrome Biobank Consortium: A perspective
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- The Alzheimer's Disease Neuroimaging Initiative Clinical Core
- Assessing amyloid PET positivity and cognitive function in Down syndrome to guide clinical trials targeting amyloid
- Age of Alzheimer's disease diagnosis in people with Down syndrome and associated factors: Results from the Horizon 21 European Down syndrome consortium
- Increasing sensitivity of clinical proverb tests for diagnosis of dementia
- Reply to Kljajevic's "Increasing sensitivity of clinical proverb tests for diagnosis of dementia"
- Do anti-Aβ monoclonal antibodies lower brain plaques in Alzheimer patients through microglia activation?
- Asian Cohort for Alzheimer's Disease (ACAD) pilot study on genetic and non-genetic risk factors for Alzheimer's disease among Asian Americans and Canadians
- Experimental laboratory models as tools for understanding modifiable dementia risk
- Entorhinal-based path integration selectively predicts midlife risk of Alzheimer's disease
- Liver integrity and the risk of Alzheimer's disease and related dementias
- Association of MGMT and BIN1 genes with Alzheimer's disease risk across sex and APOE ε4 status
- Symptoms and age of prodromal Alzheimer's disease in Down syndrome: a systematic review and meta-analysis
- Social frailty and the incidence of motoric cognitive risk syndrome in older adults
- Genome-wide association studies identify novel loci in rapidly progressive Alzheimer's disease
- Mapping morbidity 10 years prior to a diagnosis of young onset Alzheimer's disease
- Analytical and clinical validation of Alzheimer's disease blood biomarkers with a focus on plasma p-tau217
- The impact of maternal smoking during pregnancy and the age of smoking initiation on incident dementia: A prospective cohort study
- Mapping racial and ethnic healthcare disparities for persons living with dementia: A scoping review
- Dementia, dementia's risk factors and premorbid brain structure are concentrated in disadvantaged areas: National register and birth-cohort geographic analyses
- Associations of blood cell indices and anemia with risk of incident dementia
- Evidence for a novel neuronal mechanism driving Alzheimer's disease, upstream of amyloid
- Reframing motherhood in dementia research: A call for action
- Advancements in dementia research, diagnostics, and care in Latin America: Highlights from the 2023 Alzheimer's Association International conference satellite symposium in Mexico City
- Withdrawal: Glycine transporter 1 (GlyT1) is a novel therapeutic target for Alzheimer's disease
- Artificial intelligence for dementia genetics and omics
- Age at cardiovascular disease onset, dementia risk, and the role of lifestyle factors
- "Association of blood cell indices and anemia with risk of incident dementia": Missing important covariates in MRI analysis may be misleading
- Retina pathology as a target for biomarkers for Alzheimer's disease: Current status, ophthalmopathological background, challenges, and future directions
- Diabetes accelerates Alzheimer's disease progression in the first year post mild cognitive impairment diagnosis
- Walking the talk for dementia: A unique immersive, embodied, and multi-experiential initiative
- Extended genome-wide association study employing the African genome resources panel identifies novel susceptibility loci for Alzheimer's disease in individuals of African ancestry
- Dementia and mortality in older adults: A twin study
- A novel neuroimaging signature for ADRD risk stratification in the community
- The 2022 symposium on dementia and brain aging in low- and middle-income countries: Highlights on research, diagnosis, care, and impact
- HbA(1c) variability associated with dementia risk in people with type 2 diabetes
- Novel measures of cognition and function for the AD spectrum in the Novel Measures for Alzheimer's Disease Prevention Trials (NoMAD) project: Psychometric properties, convergent validation, and contrasts with established measures
- Identifying individuals with non-Alzheimer's disease co-pathologies: A precision medicine approach to clinical trials in sporadic Alzheimer's disease
- How donanemab data address the coverage with evidence development questions
- Rare Case of a 20p13 Duplication Trisomy With Craniostenosis
- Lewy body pathology modifies risk factors for cerebral amyloid angiopathy when comorbid with Alzheimer's disease pathology
- Periodontitis and brain magnetic resonance imaging markers of Alzheimer's disease and cognitive aging
- Neuroimaging correlates of Alzheimer's disease biomarker concentrations in a racially diverse high-risk cohort of middle-aged adults
- Association between household size and risk of incident dementia in the UK Biobank study
- Antidepressant exposure and long-term dementia risk in a nationwide retrospective study on US veterans with midlife major depressive disorder
- Early-onset dementia and risk of hip fracture and major osteoporotic fractures
- Predictors and outcomes of fluctuations in the clinical dementia rating scale
- Cancer research provides a model for advancing clinical trials in dementia in the era of disease-modifying Alzheimer's-type dementia therapies
- Contributions of the ADNI Biostatistics Core
- Association of neuroticism with incident dementia, neuroimaging outcomes, and cognitive function
- How many future dementia cases would be missed by a high-risk screening program? A retrospective cohort study in a population-based cohort
- A systematic review/meta-analysis of prevalence and incidence rates illustrates systemic underrepresentation of individuals racialized as Asian and/or Asian-American in ADRD research
- A Framework for Best Practices and Readiness in the Advent of Anti-Amyloid Therapy for Early Alzheimer's Disease in Asia
- Decentralized clinical trials for medications to reduce the risk of dementia: Consensus report and guidance
- Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study
- Clinical Manifestations
- Effects of the active amyloid beta immunotherapy CAD106 on PET measurements of amyloid plaque deposition in cognitively unimpaired APOE ε4 homozygotes
- The risk of Alzheimer's disease and cognitive impairment characteristics in eight mental disorders: A UK Biobank observational study and Mendelian randomization analysis
- Investigating the impact of hypertension with and without diabetes on Alzheimer's disease risk: A clinico-pathological study
- Assessment of neurovascular uncoupling: APOE status is a key driver of early metabolic and vascular dysfunction
- ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies Consortium
- Brain metabolic network covariance and aging in a mouse model of Alzheimer's disease
- Personality predictors of dementia diagnosis and neuropathological burden: An individual participant data meta-analysis
- Management of neuropsychiatric symptoms in dementia
- Subsyndromes and symptom clusters: Multilevel factor analysis of behavioral and psychological symptoms of dementia with intensive longitudinal data